Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Smok Cessat. 2019 Mar 11;14(3):168–175. doi: 10.1017/jsc.2019.1

Table 2:

Six month post-intervention outcomes and process variables

Total
n (%)
Case
Management
n (%)
Standard
Care Control
n (%)
p-value
OUTCOME VARIABLES
Use of pharmacotherapy (PP) 7/55 (12.7) 6/28 (21.4) 1/27 (3.7) 0.10*
Use of pharmacotherapy (ITT) 7/80 (8.7) 6/40 (15.0) 1/40 (2.5) 0.10*
Use of quitline (PP) 7/55 (12.7) 5/28 (17.8) 2/27 (7.4) 0.42*
Use of quitline (ITT) 7/80 (8.7) 5/40 (12.5) 2/40 (5.0) 0.43*
7-day point prevalence abstinence (PP) 15/55 (27.2) 8/28 (28.5) 7/27 (25.9) 0.82
7-day point prevalence abstinence (ITT) 15/80 (18.7) 8/40 (20.0) 7/40 (17.5) 0.77
PROCESS VARIABLES
Reasons for not using pharmacotherapy A
They thought it was expensive 29/48 (60.4) 10/22 (45.4) 19/26 (73.0) 0.05
They thought it was hard to access 25/48 (52.0) 11/22 (50.0) 14/26 (53.8) 0.79
They thought it had side effects 30/48 (62.5) 13/22 (59.0) 17/26 (65.3) 0.65
They thought it was not effective to quit smoking 28/48 (58.3) 13/22 (59.0) 15/26 (57.6) 0.92
They thought it was addictive 29/48 (60.4) 13/22 (59.0) 16/26 (61.5) 0.86
They wanted to quit without pharmacotherapy 36/48 (75.0) 16/22 (72.7) 20/26 (76.9) 0.74
They thought obtaining pharmacotherapy would take too long 29/48 (60.4) 12/22 (54.5) 17/26 (65.3) 0.44
They thought obtaining pharmacotherapy required too much paperwork 26/48 (54.1) 10/22 (45.4) 16/26 (61.5) 0.26
Reasons for not using quitline B
The quitline never called back after they contacted them 11/48 (22.9) 4/23 (17.3) 7/25 (28.0) 0.49*
They did not like talking to counselors 11/48 (22.9) 4/23 (17.1) 7/25 (28.0) 0.49*
They were not available when the quitline called 10/48 (20.8) 5/23 (21.7) 5/25 (20.0) 0.88
They did not think counseling is an effective method to quit 12/48 (25.0) 5/23 (21.7) 7/25 (28.0) 0.61
Approval for cessation resources
Applied for pharmaceutical assistance program 8/80 (10.0) 8/40 (20.0) 0/40 (0) 0.005*
Approved by pharmaceutical assistance program 8/8 (100) 8/8 (100) 0/0 (0) -

Boldface indicates statistical significance (p<0.05)

PP: Per-protocol

ITT: Intent-to treat: none of the missing cases used cessation resources or quit

A:

analysis excludes participants lost to follow-up and those who self-reported using pharmacotherapy

B:

analysis excludes participants lost to follow-up and those who self-reported using the quitline.

*

Fisher’s exact probability test